{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:11:41Z","timestamp":1766391101338},"reference-count":27,"publisher":"Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v103.12343","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T12:13:20Z","timestamp":1687868000000},"page":"adv12343","source":"Crossref","is-referenced-by-count":7,"title":["First Use of Tapinarof Monotherapy for Seborrhoeic Dermatitis: A Case Report"],"prefix":"10.2340","volume":"103","author":[{"given":"Naiem T.","family":"Issa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"34298","doi-asserted-by":"crossref","unstructured":"Szepietowski JC, Reich A, Weso\u0142owska-Szepietowska E, Baran E, Group NQoLiD. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses 2009; 52: 357-363.","DOI":"10.1111\/j.1439-0507.2008.01624.x"},{"key":"34299","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1439-0507.2008.01624.x","DOI":"10.1111\/j.1439-0507.2008.01624.x"},{"key":"34300","doi-asserted-by":"crossref","unstructured":"Jackson JM, Alexis A, Zirwas M, Taylor S. Unmet needs for patients with seborrheic dermatitis. J Am Acad Dermatol 2022 Dec 17 [Online ahead of print].","DOI":"10.1016\/j.jaad.2022.12.017"},{"key":"34301","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2022.12.017","DOI":"10.1016\/j.jaad.2022.12.017"},{"key":"34302","doi-asserted-by":"crossref","unstructured":"Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol 2015; 3: 10.13188\/2373-1044.1000019.","DOI":"10.13188\/2373-1044.1000019"},{"key":"34303","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.13188\/2373-1044.1000019","DOI":"10.13188\/2373-1044.1000019"},{"key":"34304","doi-asserted-by":"crossref","unstructured":"Keam SJ. Tapinarof cream 1%: first approval. Drugs 2022; 82: 1221-1228.","DOI":"10.1007\/s40265-022-01748-6"},{"key":"34305","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40265-022-01748-6","DOI":"10.1007\/s40265-022-01748-6"},{"key":"34306","doi-asserted-by":"crossref","unstructured":"Adalsteinsson JA, Kaushik S, Muzumdar S, Guttman-Yassky E, Ungar J. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Exp Dermatol 2020; 29: 481-489.","DOI":"10.1111\/exd.14091"},{"key":"34307","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/exd.14091","DOI":"10.1111\/exd.14091"},{"key":"34308","unstructured":"Gary G. Optimizing treatment approaches in seborrheic dermatitis. J Clin Aesthet Dermatol 2013; 6: 44."},{"key":"34309","doi-asserted-by":"crossref","unstructured":"Kastarinen H, Okokon EO, Verbeek JH. Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review. JAMA Dermatol 2015; 151: 221-222.","DOI":"10.1001\/jamadermatol.2014.3186"},{"key":"34310","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jamadermatol.2014.3186","DOI":"10.1001\/jamadermatol.2014.3186"},{"key":"34311","doi-asserted-by":"crossref","unstructured":"Nogueira S, Rodrigues MA, Vender R, Torres T. Tapinarof for the treatment of psoriasis. Dermatol Ther 2022; 35: e15931.","DOI":"10.1111\/dth.15931"},{"key":"34312","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/dth.15931","DOI":"10.1111\/dth.15931"},{"key":"34313","doi-asserted-by":"crossref","unstructured":"Uppal SK, Chat VS, Kearns DG, Wu JJ. Topical agents currently in phase II or phase III trials for atopic dermatitis. J Drugs Dermatol 2020; 19: 956-959.","DOI":"10.36849\/JDD.2020.5214"},{"key":"34314","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.36849\/JDD.2020.5214","DOI":"10.36849\/JDD.2020.5214"},{"key":"34315","doi-asserted-by":"crossref","unstructured":"Smith SH, Jayawickreme C, Rickard DJ, Nicodeme E, Bui T, Simmons C, et al. Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans. J Invest Dermatol 2017; 137: 2110-2119.","DOI":"10.1016\/j.jid.2017.05.004"},{"key":"34316","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jid.2017.05.004","DOI":"10.1016\/j.jid.2017.05.004"},{"key":"34317","doi-asserted-by":"crossref","unstructured":"Sutter CH, Azim S, Wang A, Bhuju J, Simpson AS, Uberoi A, et al. Ligand-activation of the aryl hydrocarbon receptor up-regulates epidermal UDP-glucose ceramide glucosyltransferase and glucosylceramides. J Invest Dermatol 2023 Mar 31 [online ahead of print].","DOI":"10.1016\/j.jid.2023.03.1662"},{"key":"34318","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jid.2023.03.1662","DOI":"10.1016\/j.jid.2023.03.1662"},{"key":"34319","doi-asserted-by":"crossref","unstructured":"Sekhon S, Koo J. Indirubin: a novel topical agent in the treatment of psoriasis. Br J Dermatol 2018; 178: 21-21.","DOI":"10.1111\/bjd.16074"},{"key":"34320","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.16074","DOI":"10.1111\/bjd.16074"},{"key":"34321","doi-asserted-by":"crossref","unstructured":"Magiatis P, Pappas P, Gaitanis G, Mexia N, Melliou E, Galanou M, et al. Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin. J Invest Dermatol 2013; 133: 2023-2030.","DOI":"10.1038\/jid.2013.92"},{"key":"34322","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/jid.2013.92","DOI":"10.1038\/jid.2013.92"},{"key":"34323","doi-asserted-by":"crossref","unstructured":"Park HB, Goddard TN, Oh J, Patel J, Wei Z, Perez CE, et al. Bacterial autoimmune drug metabolism transforms an immunomodulator into structurally and functionally divergent antibiotics. Angewandte Chemie 2020; 132: 7945-7954.","DOI":"10.1002\/ange.201916204"},{"key":"34324","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ange.201916204","DOI":"10.1002\/ange.201916204"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/12343\/19122","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/12343\/19122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T12:13:28Z","timestamp":1687868008000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/12343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":27,"URL":"https:\/\/doi.org\/10.2340\/actadv.v103.12343","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,27]]}}}